Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,032,755
+$89,882 QoQ
Shares Held
8,375
+0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#1,076
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Meridian Wealth Advisors, LLC holds $18,785,727 across 8 Drug Manufacturers - General names. AMGN ranks #3 (16.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,304 | $7,561,207 | |
| 2 | MRK |
Merck & Co., Inc.
|
25,697 | $3,302,064 | |
| 3 | AMGN |
Amgen Inc
This page
|
8,375 | $3,032,755 | |
| 4 | JNJ |
Johnson & Johnson
|
11,076 | $2,812,971 | |
| 5 | PFE |
Pfizer Inc
|
42,564 | $1,024,941 | |
| 6 | NVS |
Novartis AG
|
2,601 | $407,628 | |
| 7 | ABBV |
AbbVie Inc.
|
1,502 | $377,963 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,107 | $266,198 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,032,755 | 8,375 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,942,873 | 8,364 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,694,415 | 8,232 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,341,977 | 8,299 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,293,430 | 8,214 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,543,805 | 8,165 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,127,864 | 8,164 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,613,123 | 8,110 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $2,502,099 | 8,008 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,276,834 | 8,008 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,361,187 | 8,198 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,203,294 | 8,198 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,822,340 | 8,208 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $2,095,489 | 8,668 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $2,276,563 | 8,668 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $1,956,246 | 8,679 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $2,121,089 | 8,718 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $2,168,641 | 8,968 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,941,041 | 8,628 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,845,376 | 8,678 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,210,325 | 9,068 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,677,195 | 10,760 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $2,473,939 | 10,760 | Shares | Sole | 2021-05-07 | |
| 2020-09-30 | $2,747,215 | 10,809 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,516,390 | 10,669 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,720,974 | 8,489 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||